VANGUARD GROUP INC - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q3 2023$176,089,273
-25.2%
14,316,201
-2.2%
0.00%
-33.3%
Q2 2023$235,277,880
-2.6%
14,640,814
+5.6%
0.01%0.0%
Q1 2023$241,486,397
+91.1%
13,870,557
+1.4%
0.01%
+100.0%
Q4 2022$126,354,644
+11.4%
13,674,745
+3.8%
0.00%0.0%
Q3 2022$113,434,000
+4.5%
13,174,708
-1.1%
0.00%0.0%
Q2 2022$108,530,000
-31.1%
13,316,401
+2.7%
0.00%
-25.0%
Q1 2022$157,592,000
-64.1%
12,970,503
+0.9%
0.00%
-60.0%
Q4 2021$438,680,000
-28.2%
12,856,969
+1.5%
0.01%
-33.3%
Q3 2021$611,218,000
+10.9%
12,670,362
+3.9%
0.02%
+7.1%
Q2 2021$550,964,000
-5.0%
12,197,560
+1.4%
0.01%
-12.5%
Q1 2021$580,141,000
-3.5%
12,028,639
+7.7%
0.02%
-5.9%
Q4 2020$601,262,000
+49.8%
11,167,578
+2.6%
0.02%
+30.8%
Q3 2020$401,465,000
+15.3%
10,882,750
-3.2%
0.01%
+8.3%
Q2 2020$348,234,000
+17.0%
11,240,602
+4.3%
0.01%
-7.7%
Q1 2020$297,571,000
-3.2%
10,777,645
+2.5%
0.01%
+30.0%
Q4 2019$307,506,000
+54.2%
10,513,003
+0.8%
0.01%
+42.9%
Q3 2019$199,456,000
+11.2%
10,431,825
+27.6%
0.01%0.0%
Q2 2019$179,331,000
+51.8%
8,173,714
+41.6%
0.01%
+40.0%
Q1 2019$118,105,000
+128.8%
5,772,487
+41.0%
0.01%
+150.0%
Q4 2018$51,629,000
-12.4%
4,094,325
+6.6%
0.00%0.0%
Q3 2018$58,939,000
+45.2%
3,839,641
+24.0%
0.00%0.0%
Q2 2018$40,593,000
+62.6%
3,096,396
+1.2%
0.00%
+100.0%
Q1 2018$24,968,000
-4.7%
3,059,815
+3.5%
0.00%0.0%
Q4 2017$26,187,000
-18.5%
2,955,703
+2.4%
0.00%
-50.0%
Q3 2017$32,133,000
+31.6%
2,887,074
+6.0%
0.00%
+100.0%
Q2 2017$24,413,000
+15.5%
2,724,603
+1.7%
0.00%0.0%
Q1 2017$21,144,000
-1.4%
2,679,783
+7.1%
0.00%0.0%
Q4 2016$21,451,000
+15.2%
2,503,092
+10.5%
0.00%0.0%
Q3 2016$18,616,000
+8.7%
2,264,646
+6.3%
0.00%0.0%
Q2 2016$17,130,000
+50.4%
2,130,513
+26.1%
0.00%0.0%
Q1 2016$11,386,000
-9.4%
1,689,394
+5.8%
0.00%0.0%
Q4 2015$12,561,000
+39.4%
1,596,096
+1.5%
0.00%
Q3 2015$9,011,000
+16.2%
1,572,494
+9.7%
0.00%
-100.0%
Q2 2015$7,757,000
+26.7%
1,433,779
+9.4%
0.00%
Q1 2015$6,121,000
+22.9%
1,310,781
+9.7%
0.00%
Q4 2014$4,982,000
-18.1%
1,194,784
+2.3%
0.00%
Q3 2014$6,086,000
+134.2%
1,168,215
+49.2%
0.00%
Q2 2014$2,599,000
-10.1%
782,749
-6.0%
0.00%
Q1 2014$2,891,000
+16.9%
832,878
+22.0%
0.00%
Q4 2013$2,472,000
+21.5%
682,793
+0.7%
0.00%
Q3 2013$2,035,000
+31.2%
678,301
+74.1%
0.00%
Q2 2013$1,551,000389,6490.00%
Other shareholders
NEOGENOMICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 396,327$8,109,0006.56%
Cowen Prime Services LLC 584,766$11,964,0006.20%
1492 Capital Management LLC 269,488$5,514,0004.67%
First Light Asset Management, LLC 1,604,611$32,830,0004.27%
PERKINS CAPITAL MANAGEMENT INC 264,650$5,415,0003.56%
FALCON POINT CAPITAL, LLC 219,992$4,501,0002.45%
Granite Investment Partners, LLC 1,764,090$36,093,0002.05%
Ranger Investment Management 1,209,535$24,747,0001.79%
EMERALD ADVISERS, LLC 1,878,901$38,442,0001.56%
EMERALD MUTUAL FUND ADVISERS TRUST 1,875,759$38,378,0001.54%
View complete list of NEOGENOMICS INC shareholders